AgroScience Capital AG’s shareholders approve all proposals of the Board of Directors at the 2023 Annual General Meeting (AGM)
AgroScience Capital AG secures € 1.2 million in Equity / Venture Capital (as part of its Seed financing round) through private placement
At this year’s ordinary Annual General Meeting (AGM) AgroScience Capital AG’s shareholders approve all proposals of the Board of Directors
AgroScience Capital Group is pleased to announce the assignment of a completely new, own CAS Registry Number® (CAS RN®) to its proprietary liquid NPK fertilizer by CAS (a division of the AMERICAN CHEMICAL SOCIETY); Our globally scalable liquid NPK fertilizer (1) is produced climate-friendly (resource- and energy-efficiently with zero CO2 emission) and (2) is highly environmental-friendly (i.e., free of chloride, nitrate and polyphosphate as well as pollutants and organic or inorganic impurities). A unique differentiator. Our syntheses and products are designed to support global agriculture to climate-friendly transform into a more green and sustainable industry.
AgroScience Capital Group is delighted to learn that it has been highlighted by “StartUs Insights” as one of the Top 5 AgriTech Start-Ups (out of 417) on their current “Global Start-Up Heat Map”:
Go to Article (Source: StartUs-Insights)AgroScience Capital Group announces the international (PCT) patent registration of a new, disruptive and proven route of synthesis of liquid fertilizers (2nd Strategic Business Area) which enables the CLIMATE-FRIENDLY PRODUCTION (i.e., highly ENERGY-efficient AND CO2-neutral production) of ENVIRONMENTAL-FRIENDLY LIQUID (NPK) FERTILIZERS. By bringing this innovation to market, participants (producers, wholesalers / retailers, farmers and consumers) in this global industry can be given an ECOLOGICAL CHOICE and an INDIVIDUAL OPPORTUNITY for environmental contributions
AgroScience Capital AG announces raising CHF 1.2 million in Equity / Venture Capital (as part of its Seed financing round) through private placements
At this year’s ordinary Annual General Meeting (AGM) AgroScience Capital AG’s shareholders approved all proposals of the Board of Directors
AgroScience Capital AG announces raising CHF 2.2 million in Equity / Venture Capital (as part of its Seed financing round) through private placements
AgroScience Capital AG announces assignment of a new, own CAS Registry Number® (CAS RN®) to its proprietary, internationally patent protected chemical (active) substance by CAS (a division of the AMERICAN CHEMICAL SOCIETY); the CAS RN® is assigned to “unique, new substances” and is an “authoritative global industry standard”
AgroScience Capital AG’s shareholders unanimously re-elect all Members of the Board of Directors at the Adjourned Annual General Meeting 2020. The AGM was held by electronic means due to COVID-19
AgroScience Capital AG announces establishing of “AgroScience Capital Deutschland GmbH” as its wholly-owned subsidiary company in Germany
Scientific article in renowned international agricultural publication on our proprietary active substance (in German; Copyrights European Fruit Magazine June, 2020)
Highly efficacious active substance against "Apple scab & fire blight"; combined treatmentScientific article in renowned international agricultural publication on our proprietary active substance (in German; Copyrights Obstbau May, 2020)
Highly efficacious active substance against "Apple scab"OECD 473 non-GLP (Skin irritation) study result: AgroScience Capital AG’s active ingredient evaluated as not skin-irritating
Scientific article in renowned international agricultural publication on our proprietary active substance (in German; Copyrights Obstbau April, 2020)
Highly efficacious active substance against "Fire Blight"Segment Fungicides: 1st yr GEP efficacy field trials against powdery mildew (SPHRFU) on cucumber successful
Segment Fungicides: 1st yr GEP efficacy field trials against downy mildew of cucurbits (PSPECU) on cucumber successful
Segment Fungicides: 1st yr GEP efficacy field trials against speckled leaf blotch of wheat (SEPTTR) on winter wheat successful
Segment Fungicides: 1st yr GEP efficacy field trials against powdery mildew of cereals (ERYSGR) on winter wheat successful
OECD 471 non-GLP (Mutagenicity) study result: AgroScience Capital AG’s active ingredient evaluated as non mutagenic in AMES test
Segment Fungicides: 1st yr GEP efficacy field trials against downy mildew (PLASVI) on grapevine successful
Segment Bactericides: 3rd year GEP efficacy field trials against fire blight (ERWIAM) on apple very successful
Shareholders approve financial statements 2018 at Annual General Meeting in Zurich
OECD 107 non-GLP (Partition Coefficient (n-Octanol / Water)) study result: AgroScience Capital AG’s active ingredient evaluated non bioaccumulative
AgroScience Capital AG’s financial statements (as per IFRS & Swiss CO) for the reporting period 2018 audited by KPMG
Segment Fungicides: AgroScience Capital AG extends international GEP efficacy field trials programme to the areas of fruit-, vegetable-, cereals- and oilseed-crops
Company’s shareholder base at 20 private and institutional members
AgroScience Capital AG recommences R&D operations on its new, automated and state-of-the-art laboratory reactor system and analytical instruments
AgroScience Capital AG moves into new laboratory premises post technical tenant fit-out, inspection and receipt of operating license
AGM of AgroScience Capital AG: Shareholders approve financial statements for the extended financial year 2016-2017 at Annual General Meeting in Zurich
AgroScience Capital AG’s financial statements (as per IFRS & Swiss CO) for the extended financial year 2016-2017 audited
AgroScience Capital AG announces raising approx. CHF 1.5 million in Equity / Venture Capital and an additional approx. CHF 0.5 million Mezzanine (as part of its Seed financing round) through private placements
Segment Fungicides: 2nd yr efficacy trials against storage rots caused by Neofabrea (Gloeosporium) very successful; outperforming long-term mean and industry best practice; target crop: apple
Segment Fungicides: 3rd yr GEP efficacy field trials against scab of apple (VENTIN) on apple very successful; outperforming industry best practices for the 3rd consecutive year; economically most important disease of globally the 2nd most important fruit crop (apple; by production)
EGM passes resolutions on increase of approved share capital and selection of KPMG AG (Zug, Switzerland) as audit firm
Segment Bactericides: 2nd year GEP efficacy field trials against fire blight (ERWIAM) on apple very successful
Segment Bactericides: MIC tests against +5 commercially relevant bacteria very successfully completed
OECD 213 and 214 (acute oral and contact toxicity) study results on honey bees (Apis mellifera L.): classification “non-toxic to bees”
AgroScience Capital AG selects PricewaterhouseCoopers AG , Zug (PwC) for corporate financial services
AgroScience Capital AG to implement IFRS
AgroScience Capital AG announces raising approx. CHF 0.5 million in Equity / Venture Capital (as part of its Pre-Seed financing round) through private placements
Segment Fungicides: Greenhouse efficacy tests against +5 commercially relevant funguses very successfully completed
Segment Bactericides: entry into 2nd business segment with very successful 1st year GEP efficacy field trails against fire blight (ERWIAM) on apple
AgroScience Capital AG selects Homburger for legal advisory
Segment Fungicides: 2nd yr GEP efficacy field trials against scab of apple (VENTIN) on apple very successful
AgroScience Capital AG completes corporate design & communication concept
1st valuation of AgroScience Capital AG’s intangible assets performed by DIN 77100 certified IP management firm; based on international valuation standards
AgroScience Capital AG selected to present at SECA’s international start-up pitching event “Morning of Sevens”
Lit.research by EUROFINS on active ingredient: no hits of concern for indicated “cut-off” under Regulation (EC) 1107/2009 and Regulation (EC)1907/2006 (REACH)
AgroScience Capital AG announces raising approx. CHF 0.5 million in Equity / Venture Capital (as part of its Pre-Seed financing round) through private placements
EGM passes resolution on creation of approved share capital
Incorporation of AgroScience Capital AG
Segment Fungicides: 1st yr GEP efficacy field trials against scab of apple (VENTIN) on apple very successful
Segment Fungicides: 1st yr GLP efficacy tests against late blight of potato (PHYTIN) successful
Segment Fungicides: 1st yr GLP efficacy tests against Fusarium Sp. successful
Segment Fungicides: 1st yr GLP efficacy tests against scab of apple (VENTIN) very successful